Our findings indicate that NKG2D-induced IL-17A production directly licenses hepatocytes to produce CXCL1, CXCL2 and CCL2, which were previously shown to be crucial for neutrophil accumulation, HSC activation and fibrosis in NASH (61, 62). This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.